Filling the need for trusted information on national health issues

Private Sector Involvement

  • Your Selections:

Refine Results



Governments Must Offer Incentives, Find Creative Market Solutions For Antibiotic Development

Financial Times: We ignore the disaster in the antibiotics market at our peril Jeremy Farrar, director of the Wellcome Trust “…Decades of disinvestment have left perilously few companies active in antibiotic development. Those remaining are often dependent on support from philanthropic or public funders. … The tragedy is not that…

USAID Report Explores Need To Stimulate Private Capital For Global Health Innovation

USAID Center for Innovation and Impact: Unleashing Private Capital for Global Health Innovation “This report, Unleashing Private Capital for Global Health Innovation, is our contribution to understanding both innovator challenges in successfully attracting private capital to scale their solutions and investor challenges to deploying more private capital. We consulted with…

GSK, Partners To Begin Pilot Program For Malaria Vaccine In Africa This Month; Sanaria Experimental Malaria Vaccine To Begin Large Trial On African Island In 2020

Bloomberg: Malaria Vaccine Took 30 Years. It’s Still a Work in Progress “After more than three decades of work and almost $1 billion of investment, GlaxoSmithKline Plc and its partners are ready to deploy a vaccine for malaria, the mosquito-borne disease that kills almost half a million people each year.…

More News In Global Health

Agence France-Presse: Push to cure hepatitis B, a neglected disease (4/10). Al Jazeera: Death toll from devastating Cyclone Idai rises above 1,000 (4/10). Borgen Magazine: How Drug Manufacturers are Treating Neglected Tropical Diseases (Sharek, 4/10). Malay Mail: Rights advocates worry conservatism hampering women’s sexual, reproductive health (Zurairi AR, 4/11). NPR:…